Filana Therapeutics, Inc.(FLNA)

Biotechnology · Austin, TX

$0.85-0.02 (-1.79%)

Delayed quote: Oct 6, 2026, 11:54 AM EDT

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T15:56:22.781Z.

Stored calculation inputs

Calculation as of: 2026-10-06T15:56:22.781Z.

Quote observation: 2026-10-06T15:54:32.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 0.8542
Unrounded diluted TTM EPS · period ending 2026-06-30: -0.87

FMP input reference: 1e37222dd90dbab5e03bfa1bbf20eaf6e61690ec1e62f49524765e66f30de265

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

FLNA PE Ratio Metrics

PE RATIO

N/A

FLNA Competitors' PE Ratio

FLNA

Filana Therapeutics, Inc.

Current

Market Cap

$41.26M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PRPO

Precipio, Inc.

vs FLNA

Market Cap

$41.92M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MGX

Metagenomi, Inc. Common Stock

vs FLNA

Market Cap

$40.00M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NEPH

Nephros, Inc.

vs FLNA

Market Cap

$39.90M

PE Ratio

23.16

TTM Avg

36.35

3Y Avg

61.12

5Y Avg

61.12

BSEM

BioStem Technologies, Inc.

vs FLNA

Market Cap

$42.97M

PE Ratio

N/A

TTM Avg

7.83

3Y Avg

14.59

5Y Avg

14.59

HBIO

Harvard Bioscience, Inc.

vs FLNA

Market Cap

$38.92M

PE Ratio

N/A

TTM Avg

328.93

3Y Avg

271.56

5Y Avg

151.89

NNOX

Nano-X Imaging Ltd.

vs FLNA

Market Cap

$44.03M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IXHL

Incannex Healthcare Limited

vs FLNA

Market Cap

$38.35M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RPID

Rapid Micro Biosystems, Inc.

vs FLNA

Market Cap

$44.31M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DRIO

DarioHealth Corp.

vs FLNA

Market Cap

$44.35M

PE Ratio

8.79

TTM Avg

6.98

3Y Avg

6.98

5Y Avg

6.98

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Filana Therapeutics, Inc. (FLNA)	$41.26M	N/A	N/A	N/A	N/A
Precipio, Inc. (PRPO)vs ›	$41.92M	N/A	N/A	N/A	N/A
Metagenomi, Inc. Common Stock (MGX)vs ›	$40.00M	N/A	N/A	N/A	N/A
Nephros, Inc. (NEPH)vs ›	$39.90M	23.16	36.35	61.12	61.12
BioStem Technologies, Inc. (BSEM)vs ›	$42.97M	N/A	7.83	14.59	14.59
Harvard Bioscience, Inc. (HBIO)vs ›	$38.92M	N/A	328.93	271.56	151.89
Nano-X Imaging Ltd. (NNOX)vs ›	$44.03M	N/A	N/A	N/A	N/A
Incannex Healthcare Limited (IXHL)vs ›	$38.35M	N/A	N/A	N/A	N/A
Rapid Micro Biosystems, Inc. (RPID)vs ›	$44.31M	N/A	N/A	N/A	N/A
DarioHealth Corp. (DRIO)vs ›	$44.35M	8.79	6.98	6.98	6.98

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$0.85

Forward EPS (Est.)

$-0.89

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

FLNA PE Ratio Metrics

FLNA Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics